Viking Therapeutics Aktie
26,71
EUR
-2,06
EUR
-7,16
%
32,45
USD
+1,07
USD
+3,41
%
Werbung
Viking Therapeutics Aktie Analyse
16.07.19 | Viking Therapeutics Outperform | Oppenheimer & Co. Inc. | |
14.03.19 | Viking Therapeutics Buy | Maxim Group | |
12.12.18 | Viking Therapeutics Buy | B. Riley FBR | |
18.09.18 | Viking Therapeutics Buy | Maxim Group | |
18.09.18 | Viking Therapeutics Buy | H.C. Wainwright & Co. | |
01.06.18 | Viking Therapeutics Buy | Laidlaw | |
31.05.18 | Viking Therapeutics Buy | Maxim Group | |
26.03.18 | Viking Therapeutics Buy | H.C. Wainwright & Co. | |
Werbung
|
|||
28.11.17 | Viking Therapeutics Buy | Maxim Group | |
10.11.17 | Viking Therapeutics Buy | H.C. Wainwright & Co. | |
17.07.17 | Viking Therapeutics Buy | H.C. Wainwright & Co. | |
24.05.16 | Viking Therapeutics Buy | Maxim Group | |
07.04.16 | Viking Therapeutics Buy | H.C. Wainwright & Co. |
Werbung
Werbung